Table 3 The laboratory characteristics of the enrolled patients at baseline
Variables | Whole | CVs | Non-CVs | Pa |
|---|---|---|---|---|
(n =386) | (n =92) | (n = 294) | ||
Triglycerides (mg/dL) | 123.6 ± 71.3 | 134.5 ± 88.3 | 120.3 ± 63.2 | 0.097 |
LDL-C (mg/dL) | 107.9 ± 30.5 | 116.7 ± 29.9 | 105.1 ± 29.8 | 0.001 |
sdLDL-C (mg/dL) | 31.0± 12.1 | 36.2± 15.2 | 29.4± 16.8 | 0.001 |
HDL-C (mg/dL) | 46.8± 15.1 | 44.2 ± 12.9 | 47.6 ± 15.1 | 0.052 |
Non-HDL-C (mg/dL) | 129.3± 34.1 | 138.3±35.5 | 126.5± 33.4 | 0.004 |
sdLDL-C/LDL-C | 0.29 ± 0.11 | 0.31 ± 0.13 | 0.28 ± 0.16 | 0.102 |
RLP-C (mg/dL) | 5.0± 3.1 | 5.6± 3.5 | 4.8± 2.7 | 0.022 |
Glucose (mg/dL) | 114.9 ±34.5 | 122.6 ±46.4 | 112.5 ± 29.5 | 0.014 |
HbA1c (%) | 6.38 ± 1.2 | 6.8 ± 1.3 | 6.25 ±1.09 | 0.001 |
ApoA-I (mg/dL) | 125.0 ± 25.3 | 119.3 ± 23.6 | 126.8 ± 27.1 | 0.018 |
ApoB (mg/dL) | 86.1 ± 21.3 | 92.1 ± 21.6 | 84.2 ± 22.1 | 0.003 |
eGFR (mL/min/1.73 m2) | 69.9 ± 19.2 | 68.8 ± 14.1 | 70.3± 15.6 | 0.411 |
hsCRP (mg/dL) | 0.54 ± 1.1 | 0.53 ± 1.3 | 0.55 ±0.98 | 0.875 |
Lp (a) (mg/dL) | 22.9 ± 24.1 | 25.1 ± 25.2 | 22.3 ±24.1 | 0.401 |